DANVERS, Mass.--(BUSINESS WIRE)--Abiomed (NASDAQ: ABMD) announces the United States Food and Drug Administration (FDA) has approved the company's investigational device exemption application to start ...
After severe heart failure, the ability of the heart to heal by forming new cells is very low. However, after receiving treatment with a supportive heart pump, the capacity of a damaged heart to ...
For decades, the medical establishment operated under a grim certainty: once a heart attack strikes, the damage is final. In the United States alone, nearly one million people die annually from heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results